Senate Files

Bills

H.R. 4317 119th Congress

PBM Reform Act of 2025

Latest action, Jul 10, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

71 cosponsors

Sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1] (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
31 D · 40 R

Referred to: House: Education and Workforce Committee; House: Energy and Commerce Committee; House: Ways and Means Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

34 clientsQ2 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

ALLIANCE FOR PATIENT ACCESS
6 reports
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
5 reports
AMERICAN COLLEGE OF RHEUMATOLOGY
5 reports
CVS HEALTH (AND SUBSIDIARIES)
5 reports
EMD SERONO INC
5 reports
INDEPENDENT INSURANCE AGENTS & BROKERS OF AMERICA
5 reports
INDEPENDENT PHARMACY COOPERATIVE
5 reports
INDEPENDENT PHARMACY COOPERATIVE
FORBES-TATE
5 reports
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
5 reports
NATIONAL MULTIPLE SCLEROSIS SOCIETY
5 reports
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
5 reports
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
E3 STRATEGIC CONSULTING GROUP
5 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
5 reports
SELECTQUOTE, INC.
VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)
5 reports
AMGEN INC
4 reports
All 25 of 46 clients
ClientLobbying firmReportsReports totalingFromToSenate
ALLIANCE FOR PATIENT ACCESS6$120KQ4 2025Q3 2026yes
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)5$19.7MQ4 2025Q3 2026yes
AMERICAN COLLEGE OF RHEUMATOLOGY5$350KQ4 2025Q3 2026yes
CVS HEALTH (AND SUBSIDIARIES)5$13.3MQ4 2025Q3 2026yes
EMD SERONO INC5$3.6MQ4 2025Q3 2026yes
INDEPENDENT INSURANCE AGENTS & BROKERS OF AMERICA5$990KQ4 2025Q3 2026yes
INDEPENDENT PHARMACY COOPERATIVE5$210KQ4 2025Q3 2026yes
INDEPENDENT PHARMACY COOPERATIVEFORBES-TATE5$0Q4 2025Q3 2026yes
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION5$1.5MQ4 2025Q3 2026yes
NATIONAL MULTIPLE SCLEROSIS SOCIETY5$360KQ4 2025Q3 2026yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION5$15.6MQ4 2025Q3 2026yes
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONE3 STRATEGIC CONSULTING GROUP5$280KQ4 2025Q3 2026yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA5$44.0MQ4 2025Q3 2026yes
SELECTQUOTE, INC.VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC)5$300KQ4 2025Q3 2026yes
AMGEN INC4$11.7MQ4 2025Q3 2026yes
CHRONIC CARE POLICY ALLIANCE4$40KQ4 2025Q3 2026yes
FOOD MARKETPLACE INC4$2.3MQ4 2025Q2 2026yes
GSK (FKA GLAXOSMITHKLINE INC.)4$4.9MQ4 2025Q3 2026yes
NATIONAL ASSOCIATION OF CHAIN DRUG STORES4$1.4MQ3 2025Q3 2026yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATIONEMERGENT STRATEGIES4$0Q4 2025Q3 2026yes
PUBLIX SUPER MARKETSBRUMIDI GROUP4$0Q4 2025Q2 2026yes
AMERICAN PHARMACIES, INC.ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)3$180KQ4 2025Q1 2026yes
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)3$860KQ4 2025Q1 2026yes
CYSTIC FIBROSIS FOUNDATION3$660KQ4 2025Q2 2026yes
WAKEFERN FOOD CORP.3$0Q4 2025Q1 2026yes